MRA Advisory Group Raises Position in Axon Enterprise, Inc. (NASDAQ:AXON)

MRA Advisory Group lifted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 64.4% in the 4th quarter, Holdings Channel reports. The fund owned 3,205 shares of the biotechnology company’s stock after acquiring an additional 1,255 shares during the quarter. Axon Enterprise accounts for 1.0% of MRA Advisory Group’s holdings, making the stock its 22nd biggest holding. MRA Advisory Group’s holdings in Axon Enterprise were worth $1,905,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in AXON. Marion Wealth Management bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $241,000. Friedenthal Financial raised its stake in Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after buying an additional 1,231 shares during the last quarter. Brookstone Capital Management boosted its holdings in Axon Enterprise by 27.0% in the fourth quarter. Brookstone Capital Management now owns 974 shares of the biotechnology company’s stock worth $579,000 after acquiring an additional 207 shares in the last quarter. Winthrop Advisory Group LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth $236,000. Finally, Czech National Bank increased its holdings in shares of Axon Enterprise by 7.4% during the fourth quarter. Czech National Bank now owns 15,707 shares of the biotechnology company’s stock valued at $9,335,000 after acquiring an additional 1,082 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, JMP Securities increased their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $504.92.

Axon Enterprise Stock Performance

AXON opened at $568.68 on Tuesday. Axon Enterprise, Inc. has a 12-month low of $246.99 and a 12-month high of $698.67. The company has a market cap of $43.36 billion, a price-to-earnings ratio of 146.95, a PEG ratio of 14.19 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average is $610.03 and its 200 day moving average is $452.93.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock worth $30,721,337 in the last 90 days. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.